Global Gene Therapy-based Drug Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
LPI (LP Information)' newest research report, the “Gene Therapy-based Drug Industry Forecast” looks at past sales and reviews total world Gene Therapy-based Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy-based Drug sales for 2023 through 2029. With Gene Therapy-based Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy-based Drug industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy-based Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy-based Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy-based Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy-based Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy-based Drug.
The global Gene Therapy-based Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy-based Drug players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy-based Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
LPI (LP Information)' newest research report, the “Gene Therapy-based Drug Industry Forecast” looks at past sales and reviews total world Gene Therapy-based Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy-based Drug sales for 2023 through 2029. With Gene Therapy-based Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy-based Drug industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy-based Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy-based Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy-based Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy-based Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy-based Drug.
The global Gene Therapy-based Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy-based Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy-based Drug players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy-based Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Viral Gene Delivery System
- Non-viral Gene Delivery System
- Neurological Diseases
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy-based Drug Market Size 2018-2029
2.1.2 Gene Therapy-based Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Therapy-based Drug Segment by Type
2.2.1 Viral Gene Delivery System
2.2.2 Non-viral Gene Delivery System
2.3 Gene Therapy-based Drug Market Size by Type
2.3.1 Gene Therapy-based Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
2.4 Gene Therapy-based Drug Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Gene Therapy-based Drug Market Size by Application
2.5.1 Gene Therapy-based Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
3 GENE THERAPY-BASED DRUG MARKET SIZE BY PLAYER
3.1 Gene Therapy-based Drug Market Size Market Share by Players
3.1.1 Global Gene Therapy-based Drug Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy-based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY-BASED DRUG BY REGIONS
4.1 Gene Therapy-based Drug Market Size by Regions (2018-2023)
4.2 Americas Gene Therapy-based Drug Market Size Growth (2018-2023)
4.3 APAC Gene Therapy-based Drug Market Size Growth (2018-2023)
4.4 Europe Gene Therapy-based Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Therapy-based Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Therapy-based Drug Market Size by Country (2018-2023)
5.2 Americas Gene Therapy-based Drug Market Size by Type (2018-2023)
5.3 Americas Gene Therapy-based Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy-based Drug Market Size by Region (2018-2023)
6.2 APAC Gene Therapy-based Drug Market Size by Type (2018-2023)
6.3 APAC Gene Therapy-based Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy-based Drug by Country (2018-2023)
7.2 Europe Gene Therapy-based Drug Market Size by Type (2018-2023)
7.3 Europe Gene Therapy-based Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy-based Drug by Region (2018-2023)
8.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY-BASED DRUG MARKET FORECAST
10.1 Global Gene Therapy-based Drug Forecast by Regions (2024-2029)
10.1.1 Global Gene Therapy-based Drug Forecast by Regions (2024-2029)
10.1.2 Americas Gene Therapy-based Drug Forecast
10.1.3 APAC Gene Therapy-based Drug Forecast
10.1.4 Europe Gene Therapy-based Drug Forecast
10.1.5 Middle East & Africa Gene Therapy-based Drug Forecast
10.2 Americas Gene Therapy-based Drug Forecast by Country (2024-2029)
10.2.1 United States Gene Therapy-based Drug Market Forecast
10.2.2 Canada Gene Therapy-based Drug Market Forecast
10.2.3 Mexico Gene Therapy-based Drug Market Forecast
10.2.4 Brazil Gene Therapy-based Drug Market Forecast
10.3 APAC Gene Therapy-based Drug Forecast by Region (2024-2029)
10.3.1 China Gene Therapy-based Drug Market Forecast
10.3.2 Japan Gene Therapy-based Drug Market Forecast
10.3.3 Korea Gene Therapy-based Drug Market Forecast
10.3.4 Southeast Asia Gene Therapy-based Drug Market Forecast
10.3.5 India Gene Therapy-based Drug Market Forecast
10.3.6 Australia Gene Therapy-based Drug Market Forecast
10.4 Europe Gene Therapy-based Drug Forecast by Country (2024-2029)
10.4.1 Germany Gene Therapy-based Drug Market Forecast
10.4.2 France Gene Therapy-based Drug Market Forecast
10.4.3 UK Gene Therapy-based Drug Market Forecast
10.4.4 Italy Gene Therapy-based Drug Market Forecast
10.4.5 Russia Gene Therapy-based Drug Market Forecast
10.5 Middle East & Africa Gene Therapy-based Drug Forecast by Region (2024-2029)
10.5.1 Egypt Gene Therapy-based Drug Market Forecast
10.5.2 South Africa Gene Therapy-based Drug Market Forecast
10.5.3 Israel Gene Therapy-based Drug Market Forecast
10.5.4 Turkey Gene Therapy-based Drug Market Forecast
10.5.5 GCC Countries Gene Therapy-based Drug Market Forecast
10.6 Global Gene Therapy-based Drug Forecast by Type (2024-2029)
10.7 Global Gene Therapy-based Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene Therapy-based Drug Product Offered
11.1.3 Biogen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene Therapy-based Drug Product Offered
11.2.3 Novartis Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene Therapy-based Drug Product Offered
11.3.3 Gilead Sciences Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene Therapy-based Drug Product Offered
11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene Therapy-based Drug Product Offered
11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene Therapy-based Drug Product Offered
11.6.3 Amgen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene Therapy-based Drug Product Offered
11.7.3 Spark Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene Therapy-based Drug Product Offered
11.8.3 Akcea Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio Gene Therapy-based Drug Product Offered
11.9.3 bluebird bio Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Gene Therapy-based Drug Product Offered
11.10.3 Sunway Biotech Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Gene Therapy-based Drug Product Offered
11.11.3 SIBIONO Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Gene Therapy-based Drug Product Offered
11.12.3 AnGes Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Gene Therapy-based Drug Product Offered
11.13.3 Orchard Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Gene Therapy-based Drug Product Offered
11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy-based Drug Market Size 2018-2029
2.1.2 Gene Therapy-based Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Therapy-based Drug Segment by Type
2.2.1 Viral Gene Delivery System
2.2.2 Non-viral Gene Delivery System
2.3 Gene Therapy-based Drug Market Size by Type
2.3.1 Gene Therapy-based Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
2.4 Gene Therapy-based Drug Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Gene Therapy-based Drug Market Size by Application
2.5.1 Gene Therapy-based Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
3 GENE THERAPY-BASED DRUG MARKET SIZE BY PLAYER
3.1 Gene Therapy-based Drug Market Size Market Share by Players
3.1.1 Global Gene Therapy-based Drug Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy-based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY-BASED DRUG BY REGIONS
4.1 Gene Therapy-based Drug Market Size by Regions (2018-2023)
4.2 Americas Gene Therapy-based Drug Market Size Growth (2018-2023)
4.3 APAC Gene Therapy-based Drug Market Size Growth (2018-2023)
4.4 Europe Gene Therapy-based Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Therapy-based Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Therapy-based Drug Market Size by Country (2018-2023)
5.2 Americas Gene Therapy-based Drug Market Size by Type (2018-2023)
5.3 Americas Gene Therapy-based Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy-based Drug Market Size by Region (2018-2023)
6.2 APAC Gene Therapy-based Drug Market Size by Type (2018-2023)
6.3 APAC Gene Therapy-based Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy-based Drug by Country (2018-2023)
7.2 Europe Gene Therapy-based Drug Market Size by Type (2018-2023)
7.3 Europe Gene Therapy-based Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy-based Drug by Region (2018-2023)
8.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY-BASED DRUG MARKET FORECAST
10.1 Global Gene Therapy-based Drug Forecast by Regions (2024-2029)
10.1.1 Global Gene Therapy-based Drug Forecast by Regions (2024-2029)
10.1.2 Americas Gene Therapy-based Drug Forecast
10.1.3 APAC Gene Therapy-based Drug Forecast
10.1.4 Europe Gene Therapy-based Drug Forecast
10.1.5 Middle East & Africa Gene Therapy-based Drug Forecast
10.2 Americas Gene Therapy-based Drug Forecast by Country (2024-2029)
10.2.1 United States Gene Therapy-based Drug Market Forecast
10.2.2 Canada Gene Therapy-based Drug Market Forecast
10.2.3 Mexico Gene Therapy-based Drug Market Forecast
10.2.4 Brazil Gene Therapy-based Drug Market Forecast
10.3 APAC Gene Therapy-based Drug Forecast by Region (2024-2029)
10.3.1 China Gene Therapy-based Drug Market Forecast
10.3.2 Japan Gene Therapy-based Drug Market Forecast
10.3.3 Korea Gene Therapy-based Drug Market Forecast
10.3.4 Southeast Asia Gene Therapy-based Drug Market Forecast
10.3.5 India Gene Therapy-based Drug Market Forecast
10.3.6 Australia Gene Therapy-based Drug Market Forecast
10.4 Europe Gene Therapy-based Drug Forecast by Country (2024-2029)
10.4.1 Germany Gene Therapy-based Drug Market Forecast
10.4.2 France Gene Therapy-based Drug Market Forecast
10.4.3 UK Gene Therapy-based Drug Market Forecast
10.4.4 Italy Gene Therapy-based Drug Market Forecast
10.4.5 Russia Gene Therapy-based Drug Market Forecast
10.5 Middle East & Africa Gene Therapy-based Drug Forecast by Region (2024-2029)
10.5.1 Egypt Gene Therapy-based Drug Market Forecast
10.5.2 South Africa Gene Therapy-based Drug Market Forecast
10.5.3 Israel Gene Therapy-based Drug Market Forecast
10.5.4 Turkey Gene Therapy-based Drug Market Forecast
10.5.5 GCC Countries Gene Therapy-based Drug Market Forecast
10.6 Global Gene Therapy-based Drug Forecast by Type (2024-2029)
10.7 Global Gene Therapy-based Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene Therapy-based Drug Product Offered
11.1.3 Biogen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene Therapy-based Drug Product Offered
11.2.3 Novartis Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene Therapy-based Drug Product Offered
11.3.3 Gilead Sciences Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene Therapy-based Drug Product Offered
11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene Therapy-based Drug Product Offered
11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene Therapy-based Drug Product Offered
11.6.3 Amgen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene Therapy-based Drug Product Offered
11.7.3 Spark Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene Therapy-based Drug Product Offered
11.8.3 Akcea Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio Gene Therapy-based Drug Product Offered
11.9.3 bluebird bio Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Gene Therapy-based Drug Product Offered
11.10.3 Sunway Biotech Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Gene Therapy-based Drug Product Offered
11.11.3 SIBIONO Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Gene Therapy-based Drug Product Offered
11.12.3 AnGes Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Gene Therapy-based Drug Product Offered
11.13.3 Orchard Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Gene Therapy-based Drug Product Offered
11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy-based Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Delivery System
Table 3. Major Players of Non-viral Gene Delivery System
Table 4. Gene Therapy-based Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 7. Gene Therapy-based Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Therapy-based Drug Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Therapy-based Drug Revenue Market Share by Player (2018-2023)
Table 12. Gene Therapy-based Drug Key Players Head office and Products Offered
Table 13. Gene Therapy-based Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy-based Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Therapy-based Drug Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Therapy-based Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Therapy-based Drug Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Therapy-based Drug Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Therapy-based Drug Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Therapy-based Drug Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Therapy-based Drug Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Therapy-based Drug Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Therapy-based Drug Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Therapy-based Drug Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy-based Drug
Table 45. Key Market Challenges & Risks of Gene Therapy-based Drug
Table 46. Key Industry Trends of Gene Therapy-based Drug
Table 47. Global Gene Therapy-based Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Therapy-based Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Therapy-based Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Therapy-based Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 52. Biogen Gene Therapy-based Drug Product Offered
Table 53. Biogen Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 57. Novartis Gene Therapy-based Drug Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 62. Gilead Sciences Gene Therapy-based Drug Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 67. Sarepta Therapeutics Gene Therapy-based Drug Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Gene Therapy-based Drug Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 77. Amgen Gene Therapy-based Drug Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 82. Spark Therapeutics Gene Therapy-based Drug Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 87. Akcea Therapeutics Gene Therapy-based Drug Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. bluebird bio Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 92. bluebird bio Gene Therapy-based Drug Product Offered
Table 93. bluebird bio Main Business
Table 94. bluebird bio Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 97. Sunway Biotech Gene Therapy-based Drug Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 102. SIBIONO Gene Therapy-based Drug Product Offered
Table 103. SIBIONO Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 107. AnGes Gene Therapy-based Drug Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 112. Orchard Therapeutics Gene Therapy-based Drug Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 117. Human Stem Cells Institute Gene Therapy-based Drug Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Human Stem Cells Institute Latest Developments
Table 1. Gene Therapy-based Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Delivery System
Table 3. Major Players of Non-viral Gene Delivery System
Table 4. Gene Therapy-based Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 7. Gene Therapy-based Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Therapy-based Drug Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Therapy-based Drug Revenue Market Share by Player (2018-2023)
Table 12. Gene Therapy-based Drug Key Players Head office and Products Offered
Table 13. Gene Therapy-based Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy-based Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Therapy-based Drug Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Therapy-based Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Therapy-based Drug Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Therapy-based Drug Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Therapy-based Drug Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Therapy-based Drug Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Therapy-based Drug Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Therapy-based Drug Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Therapy-based Drug Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Therapy-based Drug Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Therapy-based Drug Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Therapy-based Drug Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy-based Drug
Table 45. Key Market Challenges & Risks of Gene Therapy-based Drug
Table 46. Key Industry Trends of Gene Therapy-based Drug
Table 47. Global Gene Therapy-based Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Therapy-based Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Therapy-based Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Therapy-based Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 52. Biogen Gene Therapy-based Drug Product Offered
Table 53. Biogen Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 57. Novartis Gene Therapy-based Drug Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 62. Gilead Sciences Gene Therapy-based Drug Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 67. Sarepta Therapeutics Gene Therapy-based Drug Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Gene Therapy-based Drug Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 77. Amgen Gene Therapy-based Drug Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 82. Spark Therapeutics Gene Therapy-based Drug Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 87. Akcea Therapeutics Gene Therapy-based Drug Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. bluebird bio Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 92. bluebird bio Gene Therapy-based Drug Product Offered
Table 93. bluebird bio Main Business
Table 94. bluebird bio Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 97. Sunway Biotech Gene Therapy-based Drug Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 102. SIBIONO Gene Therapy-based Drug Product Offered
Table 103. SIBIONO Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 107. AnGes Gene Therapy-based Drug Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 112. Orchard Therapeutics Gene Therapy-based Drug Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, Gene Therapy-based Drug Area Served and Its Competitors
Table 117. Human Stem Cells Institute Gene Therapy-based Drug Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute Gene Therapy-based Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Human Stem Cells Institute Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy-based Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy-based Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Therapy-based Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Therapy-based Drug Sales Market Share by Country/Region (2022)
Figure 8. Gene Therapy-based Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Therapy-based Drug Market Size Market Share by Type in 2022
Figure 10. Gene Therapy-based Drug in Neurological Diseases
Figure 11. Global Gene Therapy-based Drug Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Gene Therapy-based Drug in Cancer
Figure 13. Global Gene Therapy-based Drug Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Gene Therapy-based Drug in Other
Figure 15. Global Gene Therapy-based Drug Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Gene Therapy-based Drug Market Size Market Share by Application in 2022
Figure 17. Global Gene Therapy-based Drug Revenue Market Share by Player in 2022
Figure 18. Global Gene Therapy-based Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene Therapy-based Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene Therapy-based Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene Therapy-based Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene Therapy-based Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene Therapy-based Drug Value Market Share by Country in 2022
Figure 24. United States Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene Therapy-based Drug Market Size Market Share by Region in 2022
Figure 29. APAC Gene Therapy-based Drug Market Size Market Share by Type in 2022
Figure 30. APAC Gene Therapy-based Drug Market Size Market Share by Application in 2022
Figure 31. China Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene Therapy-based Drug Market Size Market Share by Country in 2022
Figure 38. Europe Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene Therapy-based Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene Therapy-based Drug Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gene Therapy-based Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy-based Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Therapy-based Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Therapy-based Drug Sales Market Share by Country/Region (2022)
Figure 8. Gene Therapy-based Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Therapy-based Drug Market Size Market Share by Type in 2022
Figure 10. Gene Therapy-based Drug in Neurological Diseases
Figure 11. Global Gene Therapy-based Drug Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Gene Therapy-based Drug in Cancer
Figure 13. Global Gene Therapy-based Drug Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Gene Therapy-based Drug in Other
Figure 15. Global Gene Therapy-based Drug Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Gene Therapy-based Drug Market Size Market Share by Application in 2022
Figure 17. Global Gene Therapy-based Drug Revenue Market Share by Player in 2022
Figure 18. Global Gene Therapy-based Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene Therapy-based Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene Therapy-based Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene Therapy-based Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene Therapy-based Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene Therapy-based Drug Value Market Share by Country in 2022
Figure 24. United States Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene Therapy-based Drug Market Size Market Share by Region in 2022
Figure 29. APAC Gene Therapy-based Drug Market Size Market Share by Type in 2022
Figure 30. APAC Gene Therapy-based Drug Market Size Market Share by Application in 2022
Figure 31. China Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene Therapy-based Drug Market Size Market Share by Country in 2022
Figure 38. Europe Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene Therapy-based Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene Therapy-based Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene Therapy-based Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene Therapy-based Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene Therapy-based Drug Market Size Market Share Forecast by Application (2024-2029)
